AnxA1 and its interaction with FPR receptors has potentially numerous therapeutic applications in the context of acute and chronic inflammation and cancer (Section 2.1, Section 2.2, Section 2.3 and Section 2.4). This evidence concerns the gene ANXA1 and cancer.